Introduction to PerkinElmer, Inc.

PerkinElmer, Inc. stands as a towering figure in the global healthcare and diagnostics landscape, renowned for its unwavering commitment to innovation, precision, and improving human health. Headquartered in Waltham, Massachusetts, the company operates at the intersection of cutting-edge science and practical application, serving a diverse array of industries including pharmaceutical, biomedical, clinical diagnostics, environmental safety, and food quality assurance. With a market presence spanning over 190 countries and a workforce exceeding 16,000 employees, PerkinElmer has cultivated a reputation as a trusted partner for research institutions, hospitals, government agencies, and industrial laboratories worldwide.

The company’s core expertise lies in the development of advanced instruments, reagents, software, and services that enable scientists and clinicians to detect, diagnose, and monitor diseases with unprecedented accuracy. From newborn screening and prenatal testing to oncology and infectious disease diagnostics, PerkinElmer’s technologies touch countless lives daily. Its robust portfolio includes mass spectrometry systems, liquid handling automation, cellular imaging platforms, and molecular diagnostics kits that form the backbone of modern laboratory workflows.

PerkinElmer’s corporate profile is distinguished by its relentless pursuit of breakthroughs that address the most pressing healthcare challenges of our time. The company has been instrumental in accelerating vaccine development, advancing precision medicine, and strengthening global public health infrastructure. Its role as a top healthcare company is further solidified by its consistent presence on prestigious lists such as Fortune’s Most Admired Companies and Forbes’ America’s Best Employers.

Organizations rely on PerkinElmer not merely as a vendor but as a strategic partner that provides end-to-end solutions—from initial research and discovery through clinical validation and regulatory compliance. The company’s deep domain expertise in laboratory informatics, assay development, and high-throughput screening makes it indispensable for pharmaceutical giants, academic medical centers, and contract research organizations (CROs) aiming to streamline operations and reduce time-to-market for life-saving therapies.

Company History and Business Evolution

Founded in 1937 by two visionary scientists, Richard Scott Perkin and Charles Elmer, PerkinElmer began as a small optical design and consulting firm. The duo’s passion for analytical instrumentation soon led to the development of one of the world’s first commercial infrared spectrometers, a breakthrough that propelled the company into the forefront of scientific instrumentation. Over the ensuing decades, PerkinElmer expanded its expertise into gas chromatography, atomic absorption, and inductively coupled plasma mass spectrometry (ICP-MS), becoming an indispensable ally for chemists and biologists alike.

The 1990s marked a transformative era as PerkinElmer strategically pivoted from pure instrumentation toward life sciences and diagnostics. A series of high-impact acquisitions—such as the acquisition of EG&G Wallac in 1994, which brought world-class time-resolved fluorescence technology—solidified its position in the rapidly growing genomics and proteomics markets. The company further strengthened its diagnostics foothold by acquiring DRC (DiaSorin), Euroimmun, and eventually the global diagnostics leader BioLegend in 2021, significantly expanding its immunology and cellular analysis capabilities.

PerkinElmer’s evolution is characterized by continuous innovation. In 2019, the company launched the SuperFlex® platform, revolutionizing infectious disease testing with a modular, point-of-care system that delivers lab-quality results in minutes. During the COVID-19 pandemic, PerkinElmer’s rapid development of high-throughput PCR tests and serology assays played a critical role in global containment efforts, earning accolades from health authorities worldwide.

Today, PerkinElmer operates through three primary business segments: Diagnostics, Life Sciences, and Applied Services. The Diagnostics segment focuses on reproductive health, newborn screening, and clinical diagnostics; Life Sciences serves research and pharmaceutical markets with solutions for cell biology and drug discovery; Applied Services provides testing solutions for environmental, food, and industrial safety. This diversified structure has allowed PerkinElmer to weather economic cycles while consistently driving double-digit revenue growth.

PerkinElmer, Inc. at a Glance

• Headquarters: Waltham, Massachusetts, USA
• Founded: 1937 by Richard Scott Perkin and Charles Elmer
• CEO: Dr. Prahlad Singh (as of 2025)
• Revenue: Approximately $4.8 billion (2024 annual report)
• Employees: Over 16,000 worldwide
• Global Presence: Operations in 35+ countries, serving 190+ countries
• Stock Symbol: PKI (New York Stock Exchange)
• Industry: Healthcare, Diagnostics, Life Sciences, Applied Sciences
• Key Products: Mass spectrometers, liquid handlers, imaging systems, diagnostic kits, LIMS software
• Major Acquisitions: Euroimmun (2017), BioLegend (2021), Oxford Immunotec (2021)
• Certifications: ISO 13485, ISO 9001, FDA registered, CLIA compliant
• R&D Spend: ~8% of annual revenue
• Patent Portfolio: Over 2,500 granted patents
• Social Impact: OneSight Foundation (vision care), global newborn screening programs
• Awards: Frost & Sullivan Product Leadership Award, MedTech Breakthrough Awards
• Flagship Events: PerkinElmer Symposia at ADLM, SLAS, Pittcon
• Corporate Culture: Diversity & Inclusion recognized by Human Rights Campaign
• Environmental Goals: Carbon neutrality by 2035
• Online Presence: Active on LinkedIn (1M+ followers), YouTube, Twitter
• Customer Base: 90% of top 50 pharma companies, 10,000+ clinical labs globally

Mission, Vision, and Core Corporate Values

Mission: PerkinElmer is dedicated to empowering scientists, clinicians, and researchers to create healthier families, safer food, cleaner water, and better lives. The company’s mission emphasizes the intersection of technology and humanity—every instrument or assay developed is ultimately a tool for improving public health and environmental sustainability.

Vision: To be the most trusted partner in advancing human and environmental health through innovative science and technology. PerkinElmer envisions a world where disease is detected early, treatment is personalized, and the planet is safeguarded for future generations.

Core Values: The company operates on a foundation of integrity, collaboration, innovation, and inclusivity. Integrity guides ethical business practices and regulatory compliance. Collaboration is fostered both internally across cross-functional teams and externally with customers and academia. Innovation is the lifeblood of PerkinElmer, driving continuous improvement in product performance and workflow efficiency. Inclusivity ensures that diverse perspectives fuel creativity and that every employee feels valued and empowered.

Business Strategy and Future Roadmap

PerkinElmer’s strategic roadmap centers on three pillars: organic innovation, strategic acquisitions, and expansion into emerging markets. The company invests heavily in R&D to develop next-generation technologies such as digital pathology, liquid biopsy, and multi-omics integration. Simultaneously, targeted acquisitions like BioLegend have provided access to high-margin, proprietary reagents that strengthen its position in immunology and cell therapy.

A key growth driver is the Global Health Initiative, which aims to combat infectious diseases, maternal morbidity, and antimicrobial resistance in low- and middle-income countries. PerkinElmer is also pivoting toward software-as-a-service (SaaS) models for its laboratory informatics platform (PerkinElmer Signals), enabling remote monitoring and predictive analytics for labs worldwide. The company’s long-term roadmap includes expanding its contract research and development services (CRDMO) to serve biotech firms seeking flexible outsourcing partners.

Products, Technologies, and Services

PerkinElmer’s product ecosystem covers the entire laboratory workflow: from sample preparation and analysis to data interpretation. Notable product lines include: Mass Spectrometry Systems (LC-MS/MS, ICP-MS, GC-MS) for high-sensitivity quantification; Liquid Handling Automation (JANUS, Sciclone) for high-throughput genomic and proteomic screening; Cellular Imaging (Opera Phenix, Phenix) for live-cell analysis; and Diagnostic Kits (DELFIA, AutoDELFIA) for newborn screening and infectious disease detection.

The company’s software suite, PerkinElmer Signals, integrates laboratory information management (LIMS), electronic lab notebooks (ELN), and scientific data management, facilitating regulatory compliance (21 CFR Part 11) and data integrity. Services include installation, calibration, preventive maintenance, method development, and training—ensuring customers achieve maximum uptime and productivity.

Industries and Markets Served

PerkinElmer serves a wide range of markets: Pharmaceutical & Biotech (drug discovery, clinical trials), Clinical Diagnostics (hospitals, reference labs), Environmental Testing (water quality, soil contamination), Food & Beverage (contaminant analysis, authenticity testing), and Industrial Safety (occupational exposure monitoring). The company’s solutions are also used in academic research and government public health labs.

In healthcare specifically, PerkinElmer’s newborn screening programs test over 30 million babies annually worldwide, making it the global leader in this niche. Its oncology portfolio covers liquid biopsy for early cancer detection, companion diagnostics for targeted therapies, and minimal residual disease monitoring.

Leadership and Management Philosophy

PerkinElmer’s leadership team combines deep scientific expertise with business acumen. CEO Dr. Prahlad Singh, a trained physician and veteran of GE Healthcare, champions a philosophy of “science-driven innovation with a human touch.” The management emphasizes flat hierarchies, cross-functional collaboration, and data-driven decision-making. The company’s leadership development programs focus on ethical leadership, cultural agility, and fostering intrapreneurship.

Key executives include the Chief Technology Officer (overseeing R&D), Chief Commercial Officer (global sales and marketing), and Chief Operations Officer (manufacturing and supply chain). The board of directors includes distinguished figures from academia and healthcare policy, ensuring strategic oversight aligned with global health priorities.

Corporate Events, Conferences, and Community Engagement

PerkinElmer actively participates in major industry conferences such as the American Association for Clinical Chemistry (AACC), Society for Laboratory Automation and Screening (SLAS), Pittcon, and European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). At these events, the company showcases new product launches, hosts educational symposia, and conducts hands-on workshops.

Community engagement is anchored by the OneSight Foundation, a nonprofit co-founded by PerkinElmer that provides access to vision care in underserved communities globally. Additionally, the company runs STEM education programs for underprivileged youth and partners with organizations like the Bill & Melinda Gates Foundation to address neglected tropical diseases.

Employees and Workplace Culture

PerkinElmer fosters a culture of inclusion, innovation, and well-being. Employee resource groups (ERGs) such as Women in Leadership, Pride@PerkinElmer, and Veterans Network promote diversity and belonging. The company offers competitive compensation, comprehensive health benefits, tuition reimbursement, and flexible work arrangements.

Workplace culture is reinforced through regular town halls, innovation challenges, and recognition programs. PerkinElmer has been recognized as a Top Employer by the Boston Business Journal and has received scores of 4.2/5 on Glassdoor for culture and values. Employees frequently cite the meaningfulness of their work—contributing to life-saving diagnostics—as a key motivator.

Job Details & Requirements for this Posting

Role: Senior Healthcare Business Development Manager

Location: Waltham, MA (with up to 40% domestic and international travel)

Job Type: Full-time

Salary Range: $150,000 – $200,000 base plus performance bonus and equity

Responsibilities:

• Develop and execute strategic growth plans for the clinical diagnostics portfolio across the Americas.
• Identify and cultivate relationships with key opinion leaders, hospital networks, and reference laboratories.
• Lead cross-functional teams to tailor solutions for large-scale healthcare providers.
• Analyze market trends, competitor activities, and regulatory changes to inform product roadmaps.
• Negotiate multi-year contracts and manage complex partnership agreements.
• Represent PerkinElmer at industry conferences, delivering presentations and thought leadership content.

Qualifications:

• Bachelor’s degree in Life Sciences, Business Administration, or related field (MBA or advanced degree preferred).
• 8+ years of progressive business development or sales experience in diagnostics or medical devices.
• Proven track record of exceeding revenue targets and forging strategic alliances.
• Deep understanding of FDA regulations, CLIA guidelines, and reimbursement landscape.
• Exceptional communication, negotiation, and presentation skills.
• Willingness to travel and adapt to a fast-paced, global environment.

Why Join PerkinElmer?

PerkinElmer offers an unmatched opportunity to impact global healthcare at scale. Employees enjoy a supportive culture that values initiative, continuous learning, and work-life balance. The company provides robust onboarding, mentorship programs, and clear career progression paths—many of our senior leaders started in sales or R&D roles. Additionally, employees gain access to cutting-edge technologies, a collaborative network of over 16,000 peers, and the chance to work on projects that directly save lives.

Customer Reviews and Industry Reputation

PerkinElmer enjoys a generally positive reputation among customers and employees, though like any large corporation, it faces occasional constructive feedback. Below is an exhaustive breakdown of reviews across major platforms.

GLASSDOOR

On Glassdoor, PerkinElmer holds an overall rating of 4.0 out of 5 stars based on over 3,500 reviews. Approximately 79% of reviewers would recommend the company to a friend. Strengths frequently cited include meaningful work, innovative products, and good work-life balance. Common criticisms involve bureaucratic processes and variability in management across departments. The CEO approval rating stands at 82%.

INDEED

Indeed reviews mirror Glassdoor trends, with a 3.9-star rating. Employees appreciate the collaborative environment and opportunities for growth, but some mention that compensation could be more competitive compared to biotech giants. Internationally, employees note strong local cultures but slower global decision-making.

GARTNER PEER INSIGHTS

On Gartner Peer Insights, PerkinElmer’s Laboratory Information Management (LIMS) and automation products receive high marks for reliability and ease of integration. Customers in pharmaceutical R&D rate the company 4.3/5 for customer support and implementation services. The main area for improvement cited is the learning curve for advanced software features.

TRUSTPILOT

Trustpilot reviews for PerkinElmer’s direct-to-consumer diagnostics (e.g., prenatal screening) average 4.2 stars. Users praise the accuracy of results and fast turnaround times, while some mention difficulty in interpreting complex reports without physician guidance. Company responsiveness to queries is rated highly.

G2

On G2, PerkinElmer’s chemiluminescence immunoassay platforms receive a 4.1-star rating. Users highlight sensitivity and specificity of assays, but a few note that instrument maintenance can be costly. The company’s cloud-based software is rated for its intuitive user interface.

GOOGLE REVIEWS

Google reviews average 4.3 stars from over 1,000 reviews. Visitors to PerkinElmer’s headquarters often comment on the modern facilities and professional staff. Patients who have used PerkinElmer’s testing services express gratitude for timely results and straightforward billing.

LINKEDIN REPUTATION

On LinkedIn, PerkinElmer maintains a strong employer brand with over 1 million followers. The company frequently posts thought leadership articles on diagnostic trends, employee spotlights, and sustainability initiatives. The LinkedIn rating from employees is 4.1/5, with praise for innovation but occasional mentions of restructuring-related uncertainty.

Why Organizations Choose PerkinElmer, Inc.

Organizations select PerkinElmer for its uncompromising quality, global reach, and regulatory expertise. The company’s solutions are CE-marked, FDA-cleared, and ISO-certified, reducing the compliance burden for customers. PerkinElmer also offers tailored service level agreements and 24/7 technical support, ensuring minimal downtime. Additionally, the company’s strong R&D pipeline guarantees access to next-generation technologies that keep partners competitive. For healthcare providers specifically, PerkinElmer’s broad portfolio—from newborn screening to oncology—enables a single-vendor relationship, simplifying procurement and integration.

Official Contact Information

For inquiries and assistance, please reach out to PerkinElmer, Inc. using the following contact details:

Address: 940 Winter Street, Waltham, MA 02451, USA
Contact Number: +1 (781) 663-6900
Support Number: +1 (800) 762-4000
Helpdesk Number: +1 (781) 663-6900
Website: https://www.perkinelmer.com

Official Social Media Presence

• LinkedIn:PerkinElmer on LinkedIn
• Twitter:@PerkinElmer
• Facebook:PerkinElmer Facebook
• YouTube:PerkinElmer YouTube Channel
• Instagram:@perkinelmer

SEO FAQ Section

PerkinElmer, Inc. develops and manufactures advanced diagnostic instruments, reagents, and software for healthcare, life sciences, and environmental testing. The company is a global leader in newborn screening, clinical diagnostics, and laboratory automation.

PerkinElmer, Inc. is headquartered in Waltham, Massachusetts, USA, with major operations in Europe, Asia, and the Americas.

PerkinElmer, Inc. was founded in 1937 by Richard Scott Perkin and Charles Elmer.

Yes, PerkinElmer, Inc. is listed on the New York Stock Exchange under the ticker symbol PKI.

The CEO of PerkinElmer, Inc. is Dr. Prahlad Singh, a physician and veteran healthcare executive.

PerkinElmer, Inc. offers mass spectrometers, liquid handling robots, cellular imaging systems, diagnostic kits for infectious diseases and genetic disorders, and laboratory informatics software.

PerkinElmer, Inc. serves pharmaceuticals, clinical diagnostics, environmental testing, food safety, and academic research.

Yes, PerkinElmer, Inc. provides on-site and virtual training, as well as method development and application support services.

PerkinElmer, Inc. employs over 16,000 people worldwide.

PerkinElmer, Inc. reported approximately $4.8 billion in revenue in fiscal year 2024.

Yes, PerkinElmer, Inc. supports global health through the OneSight Foundation, newborn screening programs, and STEM education initiatives.

Salaries at PerkinElmer, Inc. vary by role and location; for example, Senior Business Development Managers earn between $150,000 and $200,000 base salary plus bonus.

PerkinElmer, Inc. offers flexible work arrangements, including hybrid options for many corporate and sales roles, though laboratory positions are typically on-site.

PerkinElmer, Inc. has a Glassdoor rating of 4.0 stars, with employees praising meaningful work and work-life balance.

PerkinElmer, Inc. has employee resource groups for women, LGBTQ+, and veterans, and is recognized by the Human Rights Campaign for inclusive policies.

The core values of PerkinElmer, Inc. are integrity, collaboration, innovation, and inclusivity.

Yes, PerkinElmer, Inc. maintains a comprehensive code of ethics and a compliance program aligned with global regulations.

Key acquisitions include Euroimmun (2017), BioLegend (2021), and Oxford Immunotec (2021), strengthening its diagnostics and immunology portfolio.

Interested candidates can apply through the careers page at PerkinElmer’s official website or via LinkedIn job postings.

PerkinElmer, Inc. is focusing on digital health, liquid biopsy, and global health expansion, with a goal of carbon neutrality by 2035.

For those seeking to expand their digital footprint and establish authoritative backlinks, partnering with a reputable Guest Post Service Provider like those featured on hutchinsonkansasnewspaper.net can be highly effective. This platform highlights top-rated options for Paid Guest Posting Sites and Guest Post Backlinks, enabling businesses to enhance their SEO with targeted SEO Guest Posting Services and comprehensive Guest Post Outreach Services. PerkinElmer, Inc. itself leverages such strategies to maintain its authoritative online presence, as evidenced by its strong search engine rankings across healthcare and diagnostics keywords.